期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
微量尿蛋白检测技术对早期糖尿病肾病监控的价值
1
作者 张圣芳 《中文科技期刊数据库(文摘版)医药卫生》 2021年第6期272-272,共1页
分析微量尿蛋白检测技术对早期糖尿病肾病监控的价值。方法:将本院2019年6月~2020年12月诊治的46例早期糖尿病肾病患者纳入研究组,另将本院同时期诊治的46例糖尿病患者纳入对照组,两组均运用运用Omlipo全自动特定蛋白分析仪,采用散射比... 分析微量尿蛋白检测技术对早期糖尿病肾病监控的价值。方法:将本院2019年6月~2020年12月诊治的46例早期糖尿病肾病患者纳入研究组,另将本院同时期诊治的46例糖尿病患者纳入对照组,两组均运用运用Omlipo全自动特定蛋白分析仪,采用散射比浊法检测微量尿蛋白,对比其检测值与阳性检出率。结果:研究组患者的微量尿蛋白检测值与阳性检出率(43.54±5.67mg/L、80.43%)均高于对照组(11.25±3.10mg/L、6.52%),P<0.05。结论:微量尿蛋白检测技术在早期糖尿病肾病监控中的应用价值高,可为临床诊断提供参考依据,有助于提高该病的诊断率。 展开更多
关键词 微量尿蛋白检测技术 早期糖尿病肾病 监控价值
下载PDF
国有企业财务监控权配置研究 被引量:7
2
作者 韩鹏 《财会通讯(上)》 北大核心 2006年第6期72-75,共4页
财务监控权配置是国有企业公司治理结构的一个基本命题。本文首先分析了财务监控的涵义,并定位了财务监控的主体与研究对象。在此基础上,立足于时空观构建了财务监控权配置模式,试图为财务监控的研究特别是实时财务监控的研究提供一个... 财务监控权配置是国有企业公司治理结构的一个基本命题。本文首先分析了财务监控的涵义,并定位了财务监控的主体与研究对象。在此基础上,立足于时空观构建了财务监控权配置模式,试图为财务监控的研究特别是实时财务监控的研究提供一个基本框架。 展开更多
关键词 公司治理结构财务监控价值流整合观协同观
下载PDF
论权力制衡的重心
3
作者 彭学明 《产业与科技论坛》 2006年第5期15-16,共2页
权力本身也需要监督与制约,但应强化制衡机制而不能仅靠“管官的官”。权力监控的重点是其运用效果和行为价值,包括评估滥用或不用形成的负值或者价值差异,并落脚到职位、薪酬等的调整上。横直交错的监督体系和动态调节机制之运行不可... 权力本身也需要监督与制约,但应强化制衡机制而不能仅靠“管官的官”。权力监控的重点是其运用效果和行为价值,包括评估滥用或不用形成的负值或者价值差异,并落脚到职位、薪酬等的调整上。横直交错的监督体系和动态调节机制之运行不可不注重观念的跟进。 展开更多
关键词 价值监控 牵制机制 制衡观念
下载PDF
Diagnostic and monitoring values of circulating AFPmRNA and HS-GGT for hepatocellular carcinoma
4
作者 Li Wang Min Yao +3 位作者 Yao Yao Liuhong Pan Shaolin Lu Dengfu Yao 《The Chinese-German Journal of Clinical Oncology》 CAS 2014年第10期457-463,共7页
Objective: Early finding of hepatocellular carcinoma(HCC) and monitoring of its metastasis are of the utmost importance. The objectives of this study were to investigate the values of circulating hepatoma-specific gam... Objective: Early finding of hepatocellular carcinoma(HCC) and monitoring of its metastasis are of the utmost importance. The objectives of this study were to investigate the values of circulating hepatoma-specific gamma-glutamyl transferase(HS-GGT) fraction and α-fetoprotein mRNA(AFP-mRNA) from peripheral blood mononuclear cells(PBMCs) in diagnosis or monitoring metastasis of HCC. Methods: Total RNA was extracted from hepatomas or PBMCs of patients, synthesized to AFP-cDNA through random primers and reverse transcriptase, amplified by using a nested PCR assay, and confirmed by sequencing. Simultaneity, the HS-GGT activities were quantitatively determined in sera of patients. The comprehensive assessments of two markers were investigated in HCC patients. Results: The amplified fragments of AFP-mRNA were identical to original designed ones(159 bp) and confirmed by sequencing. The lowest sensitivity was 2 ng/L of total RNA. The incidences of AFP-mRNA and HS-GGT were 60.4%(113 of 187) and 84.5%(158 of 187) in the HCC group, and their significantly higher(P < 0.01) than that in any of other groups. The high frequencies of HS-GGT and AFP-mRNA were 78.2% and 56.4% in the HCC patients with AFP < 50 ng/mL. All positive of AFP-mRNA was found in HCC patients with extrahepatic metastasis. No significant correlation was found between tumor size and AFP-mRNA or HS-GGT. The total incidence of combined AFP-mRNA and HS-GGT detection was 93.6 % for HCC diagnosis. Conclusion: HS-GGT and AFP-mRNA are specific markers for HCC diagnosis or differentiation, especially the former for early finding and the later for monitoring metastasis of HCC. 展开更多
关键词 hepatocellular carcinoma(HCC) AFP-MRNA hepatoma-specific gamma-glutamyl transferase diagnosis metastasis
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部